β³ Fetching live dividend data...
Home βΊ Calculator βΊ TAUG Dividend Calculator 2026
Tauriga Sciences, Inc. Β· OTC
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TAUG β $1.0240512011520145e+51M in 10 years Β· $85,337,173,410,134,160,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Tauriga Sciences, Inc. produces and sells cannabidiol infused chewing gum under the Tauri-Gum brand name. It also develops anti-nausea products; and skin care products include CBD facemasks; CBD daily moisturizer; CBD anti-wrinkle dream, hand, and foot cream with hemp seed oil; CBD massage and body oil; CBD body revive roll-on; CBD transdermal patch; and CBD body spray. In addition, the company offers rainbow deluxe sampler pack, CBD non-GMO dietary supplements, and CBD scented bath bombs. It sells its products through e-commerce, distributors, and wholesale channels. The company has a collaboration agreement with Aegea Biotechnologies, Inc. to develop a rapid, multiplexed COVID-19 (novel coronavirus) test. Tauriga Sciences, Inc. was founded in 2001 and is headquartered in Wappingers Falls, New York.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open TAUG position with:
Real after-tax yield depends on where you live and how you hold TAUG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| πΊπΈ US Taxable (20%) | 20% | 16000000.00% | 15999997.20% | $1,600,000,000 / yr |
| π¬π§ UK ISA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¬π§ UK Taxable | 8.75% | 18250000.00% | 18249997.20% | $1,825,000,000 / yr |
| π¨π¦ TFSA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| π¨π¦ CA Taxable | 25% | 15000000.00% | 14999997.20% | $1,500,000,000 / yr |
| π¦πΊ Super (pension) | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| π¦πΊ AU Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 14725000.00% | 14724997.20% | $1,472,500,000 / yr |
| π«π· FR Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
TAUG pays quarterly β 4 times per year. Next ex-div: TBD.
How TAUG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TAUG sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2021-05-27 | 250,000 | $20000.00 | $5000.00M | ||
| Buy | 2020-07-10 | 700,000 | $35000.00 | $24500.00M | ||
| Buy | 2017-10-06 | 110,000,000 | $137500.00 | $15125000.00M | ||
| Buy | 2017-06-21 | 44,000,000 | $55000.00 | $2420000.00M | ||
| Buy | 2017-06-15 | 76,000,000 | $95000.00 | $7220000.00M | ||
| Sale | 2016-09-14 | 600,000 | $0.00 | $2.2K | ||
| Sale | 2016-07-08 | 72,500 | $0.01 | $645.00 | ||
| A-Award | 2016-03-30 | 37,500,000 | β | β | ||
| A-Award | 2016-03-30 | 8,000,000 | β | β | ||
| A-Award | 2016-03-30 | 8,000,000 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TAUG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β